Aspartic acid-based modified PLGA-PEG nanoparticles for bone targeting: In vitro and in vivo evaluation

Bone targeting NPs comprised of dendritic trimer of aspartic acid functionalized PLGA-PEG copolymers could be the foundation for hydrophobic-drug therapies.